Filing Details

Accession Number:
0000874015-15-000039
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-09 19:27:55
Reporting Period:
2015-03-05
Filing Date:
2015-03-09
Accepted Time:
2015-03-09 19:27:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Isis Pharmaceuticals Inc ISIS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1074773 L Elizabeth Hougen C/O Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad CA 92010
Svp, Finance & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-05 12,657 $14.47 16,044 No 4 M Direct
Common Stock Disposition 2015-03-05 12,657 $71.67 3,387 No 4 S Direct
Common Stock Acquisiton 2015-03-05 8,000 $7.25 11,387 No 4 M Direct
Common Stock Disposition 2015-03-05 8,000 $71.67 3,387 No 4 S Direct
Common Stock Acquisiton 2015-03-05 7,437 $7.25 10,824 No 4 M Direct
Common Stock Disposition 2015-03-05 7,437 $71.32 3,387 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-03-05 12,657 $0.00 12,657 $14.47
Common Stock Employee Stock Option (right to buy) Disposition 2015-03-05 15,437 $0.00 15,437 $7.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-01-02 2016-01-02 No 4 M Direct
4,063 2013-01-03 2019-01-02 No 4 M Direct
Footnotes
  1. Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 2/3/2015.
  2. Grant of 1/3/2012 to reporting person of stock options under the Isis Pharmacueticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/3/2013. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 4,875 shares per year. Following this transaction, the option was exercisable as to 0 on 3/5/2015.